This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
November 3–5, 2025
Vienna Congress and Convention Center, Vienna, AustriaNovember 11–12, 2025 | Digital Partnering

Daniela Begolo
Managing Director at EQT Life Sciences
Speaker

Profile

Daniela is a Managing Director at EQT Life Sciences and she has been part of the team since 2023. While at EQT, she has invested in SpliceBio and Mosanna Therapeutics, while supporting other portfolio companies, such as Varmx. Prior to EQT, Daniela was a Principal at Inkef in Amsterdam, where she worked on several biotech investments, including Cardior (sold to Novo Nordisk for up to $1.1Bn). Before joining Inkef, she spent time at M Ventures. Daniela holds a PhD in molecular biology from Heidelberg University, obtained as an early Stage Researcher with Marie Skłodowska-Curie Actions, and MSc and BSc in Biotechnology from University of Padova.

Agenda Sessions

  • Sipping on success: SpliceBio’s Series B and the revival of gene therapy

    14:00